Literature DB >> 18052864

Human T-cell lymphotropic virus in a population of pregnant women and commercial sex workers in South Western Nigeria.

J C Forbi1, A B Odetunde.   

Abstract

BACKGROUND: Over 20 million persons are infected with HTLV-I/II globally. The virus is endemic in Africa and it is also transmitted sexually. Continued identification of high risk groups is important for the control of the disease.
OBJECTIVES: To determine the prevalence of HTLV infection amongst two highly sexually active groups, pregnant women and CSWs in South Western Nigeria.
METHODS: Serum samples were tested for the presence of HTLV-I/II antibodies using the Vironostika HTLV-I/II micro ELISA system.
RESULTS: A total of 364 serum samples collected from pregnant women, commercial sex worker (CSW) and secondary school students (control group) from Ibadan. While only 4 (5.1%) of 78 secondary school students (average age: 13 years) were reactive for HTLV infection, 20 (16.7%) of 120 pregnant women (average age: 26 years) and 38 (22.9%) of 166 CSWs (average age: 23 years) were found to have antibodies against HTLV in their sera. The results of this study thus show that HTLV infection is active in the population although higher in pregnant women (although not statistically significant) and CSWs (p>0.05). Pregnant women and CSWs are therefore at a higher risk of HTLV transmission than other members of the population.
CONCLUSION: Routine screening for HTLV infection may go a long way to understanding the epidemiology of HTLV infection in Nigeria and subsequently provide tools for its prevention and control.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18052864      PMCID: PMC2269719          DOI: 10.5555/afhs.2007.7.3.129

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  19 in total

Review 1.  The epidemiology and disease outcomes of human T-lymphotropic virus type II.

Authors:  Diana F Roucoux; Edward L Murphy
Journal:  AIDS Rev       Date:  2004 Jul-Sep       Impact factor: 2.500

2.  HTLV-negative and HTLV type I-positive tropical spastic paraparesis in northeastern Brazil.

Authors:  C M Costa; P Goubau; H F Liu; A M Vandamme; F M da Cunha; T J Santos; J Desmyter; H Carton
Journal:  AIDS Res Hum Retroviruses       Date:  1995-02       Impact factor: 2.205

3.  Some epidemiological features of the human T-cell lymphotropic virus type I (HTLV-I) and ATL in Nigerians.

Authors:  C K Williams; A Dada; W A Blattner
Journal:  Leukemia       Date:  1994-04       Impact factor: 11.528

4.  Human T-cell lymphotropic virus types I and II infections in mother-child pairs in Nigeria.

Authors:  D O Olaleye; O O Omotade; Z Sheng; A A Adeyemo; G N Odaibo
Journal:  J Trop Pediatr       Date:  1999-04       Impact factor: 1.165

5.  The seroepidemiology of human T-lymphotropic viruses: types I and II in Europe: a prospective study of pregnant women.

Authors:  Graham P Taylor; Monique Bodéus; Françoise Courtois; Georg Pauli; Annarosa Del Mistro; Ana Machuca; Elizabeth Padua; Soren Andersson; Patrick Goubau; Luigi Chieco-Bianchi; Vincent Soriano; Joliette Coste; Anthony E Ades; Jonathan N Weber
Journal:  J Acquir Immune Defic Syndr       Date:  2005-01-01       Impact factor: 3.731

6.  Seroepidemiology of HTLV-I/II in universal screening of blood donations in France.

Authors:  A M Couroucé; J Pillonel; J M Lemaire; M Maniez; J B Brunet
Journal:  AIDS       Date:  1993-06       Impact factor: 4.177

7.  Type-specific immune response to human T cell lymphotropic virus (HTLV) type I and type II infections in Nigeria.

Authors:  D O Olaleye; L Bernstein; Z Sheng; C C Ekweozor; X Y Li; J Sullivan-Halley; S Rasheed
Journal:  Am J Trop Med Hyg       Date:  1994-04       Impact factor: 2.345

8.  Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. The HTLV European Research Network.

Authors: 
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-09

9.  Seroprevalence study of HTLV-1 and HIV infection in blood donors and patients with lymphoid malignancies in Lagos, Nigeria.

Authors:  H I Analo; A S Akanmu; I Akinsete; O S Njoku; C C Okany
Journal:  Cent Afr J Med       Date:  1998-05

10.  Human T-cell lymphotropic virus types I and II infections in patients with leukaemia/lymphoma and in subjects with sexually transmitted diseases in Nigeria.

Authors:  O D Olaleye; C C Ekweozor; Z L Li; I E Opala; Z Sheng; T N Onyemenem; S Rasheed
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

View more
  6 in total

1.  From HIV AIDS, TB to H. pylori and other infections in Africa.

Authors:  James K Tumwine
Journal:  Afr Health Sci       Date:  2007-09       Impact factor: 0.927

2.  Seroprevalence of human T-cell lymphoma/leukemia virus type-1 (HTLV-1) antibodies among blood donors at Enugu, Nigeria.

Authors:  Augustine Ejike Okoye; Obike Godswill Ibegbulam; Robinson Chukwudi Onoh; Ngozi Immaculata Ugwu; Chukwudi Simon Anigbo; Charles Emeka Nonyelu
Journal:  J Blood Med       Date:  2015-01-19

3.  Seroprevalence and correlates of human T-cell lymphoma/leukemia virus type 1 antibodies among pregnant women at the University of Nigeria Teaching Hospital, Enugu, Nigeria.

Authors:  Augustine Ejike Okoye; Obike Godswill Ibegbulam; Robinson Chukwudi Onoh; Paul Olisaemeka Ezeonu; Ngozi I Ugwu; Lucky Osaheni Lawani; Chukwudi Simon Anigbo; Charles E Nonyelu
Journal:  Int J Womens Health       Date:  2014-09-18

4.  The Prevalence of Human T-Cell lymphotropic Virus Type 1 in Pregnant Women and Their Newborns.

Authors:  A Hamedi; F Akhlaghi; Z Meshkat; M Sezavar; H Nomani; M Meshkat
Journal:  ISRN Obstet Gynecol       Date:  2012-11-14

5.  Work-Related Human T-lymphotropic Virus 1 and 2 (HTLV-1/2) Infection: A Systematic Review.

Authors:  Angela Stufano; Hamid Reza Jahantigh; Francesco Cagnazzo; Francesca Centrone; Daniela Loconsole; Maria Chironna; Piero Lovreglio
Journal:  Viruses       Date:  2021-09-02       Impact factor: 5.048

Review 6.  Re-emergence of human T-lymphotropic viruses in West Africa.

Authors:  Nneoma Confidence JeanStephanie Anyanwu; Elijah Ekah Ella; Aghogho Ohwofasa; Maryam Aminu
Journal:  Braz J Infect Dis       Date:  2018-06-05       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.